ProfileGDS5822 / ILMN_2621901
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 89% 92% 92% 89% 92% 88% 92% 90% 88% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1436.789
GSM1276600PDAC Late Ablation Control 2668.292
GSM1276601PDAC Late Ablation Control 3727.692
GSM1276602PDAC Late Ablation 1419.489
GSM1276603PDAC Late Ablation 2639.392
GSM1276604PDAC Late Ablation 3427.788
GSM1303940PDAC Late Ablation_anti-CTLA4 1684.192
GSM1303941PDAC Late Ablation_anti-CTLA4 2561.590
GSM1303942PDAC Late Ablation_anti-CTLA4 3476.388